HEMEX is delighted to announce an exciting new partnership with Avanti Europe. The
Avanti Europe team is a specialist consultancy and expert knowledge provider. This
partnership will allow us to complete the range of products we provide to healthcare start-ups to ensure we continue offering excellent support within the life science industry.
Register now to the innovation promotion program where you can benefit from coaching sessions, mentoring, networking events, and extensive marketing and PR activities.
An era may have come to an end; however, the dawn of a completely new investor showcase format is just over the horizon, and with it, many incredible investment opportunities which promise to revolutionise our healthcare landscape. Stay tuned; more information is heading your way soon!
HEMEX’s Investment Showcase yesterday featured U-Sana Medical. The MedTech company has developed a new device for post-operative rehabilitation after bunion surgeries
This month’s video is all about raising awareness on ONE HEALTH and how all of us can work together to improve the health of humans, animals and protect our environment.
Every other Thursday, HEMEX showcases smart ideas and solutions from innovation-driven start-ups that aim to improve our future healthcare services. This morning, we had the pleasure of hosting a very special HEMEX Investment Showcase, where project lead, Dr. Myriam Lingg, brilliantly presented macu4’s innovative idea to revolutionize the passive-arm prosthetics market.
BLKB, Hemex and Launchpad aim to support young entrepreneurs in their business activities through the start-up incubator program, inQbator. The program is open to start-ups from all industries. The main aim of inQbator is to promote innovation in the region.
February is undeniably the month of love, kindness, and compassion. However, sometimes the society in which we live can be seen as this hostile, unfriendly, and a cruel place. Especially in the last year, we have lived through an unprecedented situation, and all of us had to adapt to a new normality. Scientific evidence shows the positive effects of doing random acts of kindness for others as well as receiving them, so why don’t we get started?
Our portfolio company Opterion Health AG seeks to enhance the quality of life for patients with end-stage renal disease (ESRD) and their loved ones, and to increase survival rates of ESRD patients. They launched their new website at the beginning of the year and have very exciting plans for 2021!
On HEMEX’s Investment Showcase today we tackled the pain, bleeding, and tissue tear that women worldwide experience when undergoing common gynaecological procedures. Our portfolio company ASPIVIX is developing the next-generation suction-based cervical device that will improve these traumatic experiences.
